Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Impressive indeed Serb. Another example of management team adjusting business strategy to capitalize on an opportunity to add revenue streams for long term growth!!
Good to see you back Insta
Solid analysis, thanks Money ??!!
List Of Market Maker Signals
1. 100 - I need Shares.
EUSA
In December 2015, the Company entered into the EUSA Agreement, under which the Company granted to EUSA the exclusive, sublicensable right to develop, manufacture and commercialize tivozanib in the territories of Europe (excluding Russia, Ukraine and the Commonwealth of Independent States), Latin America (excluding Mexico), Africa and Australasia (collectively, the “EUSA Licensed Territories”) for all diseases and conditions in humans, excluding non-oncologic diseases or conditions of the eye.
per indication in connection with a filing by EUSA with the EMA for marketing approval, if any, for tivozanib for the treatment of each of up to three additional indications and $5.0 million per indication in connection with the EMA’s grant of marketing approval for each of up to three additional indications, as well as potentially up to $335.0 million upon EUSA’s achievement of certain sales thresholds. The Company is also eligible to receive tiered double-digit royalties on net sales, if any, of licensed products in the EUSA Licensed Territories ranging from a low double digit up to mid-twenty percent depending on the level of annual net sales. No milestone payments nor research and development reimbursement payments were earned in the three months and nine months ended September 30, 2020.
indeed, healthy trading throughout the day in .16-17 range.
Could be MM signals......List Of Market Maker Signals
1. 100 - I need Shares.
2. 200 - I need Shares badly but do not take the stock down.
3. 300 - Take (or I am taking) the stock down at least 30% so I can load shares.
4. 400 - Keep trading it sideways.
5. 500 - Gap the stock. Gap can be up or down, depending on direction of 500 signal.
6. 505 - I am short on shares
7. 600 - Apply resistance at the ASK to keep the price from increasing.
8. 700 - Move the price up.
9. 777 - Also recognized as a signal to move the price up.
10. 800 - Prepare for an increase in trading volume.
11. 900 - Allow the stock to float and trade freely.
12. 911 - Pending News/Press Release On The Way
13. 1000 - Don't let it run
14. 2100 - Let it run
Hotsprgs, RXMD business model broader than shipping meds. Building full fledged Healthcare management enterprise, which happens to have license to ship scripts to 14 states to date. Take a look at the investor deck that guacamole posted. Good foundation info there..good luck
Stockforce, I recall question being asked to Mrs. Mars when he was appointed to board of directors if he might pursue CEO. Appointing Oleg would seem to be solid choice considering the NetElement/RXMD partnership. It seem appeal at that time was to tap into NET business alliances, with emphasis for RXMD to enhance IT capabilities through NETs platforms.
Agree garrox. Wacamole's post with investor slide deck.
RXMD longs not overly concerned with hour to hour fluctuations. We're sipping on a relaxing beverage .?
Serb, too many nuggets to put in our pockets at one time....
Some keys to RXMD continuing growth as the company continues shift toward becoming integrated, technology driven health services company:
-As of 30Sep2020 cash equivalents of $1.6 million.
-Continue integration of CallingDr telehealth service app.
-Continue pursue regulatory approval to expand mail order service from current 14 States to all 50.
-Expand company's COVID-19 PCR testing to include AbbottID Now and Cepheid.
Good things keep coming, solid company with dynamic adoptable healthcare business model.
Been in n out this ticker for several years as well. I keep it in play hopeful agreement talks with Sony and major auto manufacturer would have become fruitful. Would recommend take profits during surges...glta
Agree Os, seems to be another piece of the puzzle started 3yrs ago or so when the company was getting licensed to do business in 14 states. I think the thought then was to ship meds from central portal, likely Fl. Integrating app with business model is long term game changer.
GLTU
Overall irony with that is that Shital brought Oleg on as a director 3yrs or so ago. Thinking they should have had a prominent role for Shital as she had been face of RXMD during it's rise..
Count me in that group Capt....gltu
Crumbster, those are lyrics from Adele song..hello
RXMD= continuous good news. From my point of view, it seems that 2019 will likely be a key pivot point that propels the company more steadily along the path laid out by the management team. Provided the new acquisition closes, which by the way has 2 locations doing about 18mil revs currently, it really isn't too far fetched to believe the pps will follow a similar growth trajectory. The 18mil combined with current projections, mean RXMD will be tasting 40mil revs and quite possibly mid 40mil. The performance in terms of revenues and sales will be disclosed via quarterly q's and annual reports. The greater unknown in the RXMD story, will be the reaction from the marketplace. Long RXMD
Wonderful news!! Let's see upon completing this acquisition, rev probably will be 45-50 mil or so. That's not factoring in potential revs from state licensing/partnerships-RXMD still building that supply chain...some don't seem to quite fully understand where this train is headed..RXMD lonnngggggg
No doubt serb. It appears RXMD management considering opportunities for global expansion or to establish global presence via the company's supply chain. All good news indeed?
I agree stock, Mrs. Mars dropped a huge nugget on that 10mil comment. That seems to indicate they likely have targeted additional acquisitions or have some other uses of the funds toward building the business.
Definitely seems to be a long term hold, even so with the broad fluctuations in the pps. Prospects for sustainable growth intriguing.
Pidboop, one should rather consider those as capital investments used by RXMD to further it's business objectives. No worries overall, look at the performance.
None needed for this party turbo. Most investors will become exceedingly intoxicated from the growth from their investment in due time.
Seems like there may be additional news to follow this announcement about Benchmark
well deserved
Thanks Serb
T2t2, agree
Today's open letter from the CEO shows the company has a high level of commitment to achieve their stated objectives regardless of the obstacles. Even more so, you gotta appreciate the integrity and keen awareness of the external factors in play.
agree badguy.. I would suggest the latest move by our CEO is more an inventive to award those "key" employees that have stayed with the company through its growth. She made that quite clear for the recent BOD appointees as well as this latest strategic move to RECOGNIZE and RETAIN QUALITY TALENTED PROFESSIONALS through bonus awards!! It really shouldn't be much of a surprise to those who have been following RXMD. Each conf call she makes an effort to recognize her staff. That's a model well worthy of duplicating!! Holding longggg since 6/15
No doubt the release was a strategic decision to support today's presentation. It's fresh news, undisputed!!
JQ, they pr'd in May 16 they would be presenting at SeeThru Equity Microcap conf in NY. Indeed, this one has different sets of eyes...wallets
Darth, a bigger catalyst will likely come from state licenses. Once those agreements are in place with partner facilities, that goal seems reasonably attainable. From last conf call Mrs Shital said current revs only about 10% from state licenses. Imo
Likely already in play this week considering volume
Jimbo, during last conf call, Mrs. Shitel said only about 10% of reported revs were through out of state license agreements. They haven't scratched that itch through out of state license agreements yet.